全文获取类型
收费全文 | 23929篇 |
免费 | 1161篇 |
国内免费 | 159篇 |
专业分类
耳鼻咽喉 | 210篇 |
儿科学 | 543篇 |
妇产科学 | 264篇 |
基础医学 | 3255篇 |
口腔科学 | 412篇 |
临床医学 | 1447篇 |
内科学 | 6380篇 |
皮肤病学 | 582篇 |
神经病学 | 1769篇 |
特种医学 | 985篇 |
外科学 | 4015篇 |
综合类 | 123篇 |
预防医学 | 568篇 |
眼科学 | 573篇 |
药学 | 1506篇 |
中国医学 | 38篇 |
肿瘤学 | 2579篇 |
出版年
2023年 | 140篇 |
2022年 | 291篇 |
2021年 | 489篇 |
2020年 | 275篇 |
2019年 | 354篇 |
2018年 | 507篇 |
2017年 | 389篇 |
2016年 | 477篇 |
2015年 | 499篇 |
2014年 | 730篇 |
2013年 | 817篇 |
2012年 | 1395篇 |
2011年 | 1573篇 |
2010年 | 880篇 |
2009年 | 794篇 |
2008年 | 1389篇 |
2007年 | 1546篇 |
2006年 | 1509篇 |
2005年 | 1650篇 |
2004年 | 1662篇 |
2003年 | 1699篇 |
2002年 | 1570篇 |
2001年 | 297篇 |
2000年 | 256篇 |
1999年 | 345篇 |
1998年 | 411篇 |
1997年 | 327篇 |
1996年 | 316篇 |
1995年 | 271篇 |
1994年 | 244篇 |
1993年 | 221篇 |
1992年 | 182篇 |
1991年 | 156篇 |
1990年 | 142篇 |
1989年 | 130篇 |
1988年 | 125篇 |
1987年 | 110篇 |
1986年 | 112篇 |
1985年 | 104篇 |
1984年 | 110篇 |
1983年 | 81篇 |
1982年 | 77篇 |
1981年 | 78篇 |
1980年 | 72篇 |
1979年 | 58篇 |
1978年 | 50篇 |
1977年 | 47篇 |
1976年 | 40篇 |
1975年 | 33篇 |
1972年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
982.
983.
984.
Toshihiro Yoshitake Akira Takeda Kensaku Ohki Yuko Inoue Takanori Yamawaki Saori Otsuka Minekatsu Akimoto Mitsuru Nemoto Yasuhito Shimakura Akio Sato 《The Journal of dermatology》2015,42(7):735-738
Finasteride is standard medical treatment for androgenetic alopecia; however, no large studies with 5 years or more of follow up have been performed in Japan. The authors followed Japanese men with androgenetic alopecia treated with finasteride for 5 years to evaluate long‐term treatment efficacy. Of 903 men treated with finasteride (1 mg/day), 801 patients were evaluated over 5 years by modified global photographic assessment. Although the proportion of improvement was high (99.4%), modified global photographic assessment scores after 5 years of treatment were lower in patients with more advanced disease as measured by the modified Norwood–Hamilton scale. After separating patients into “sufficient” and “insufficient” efficacy groups according to the modified global photographic assessment score after 5 years (scores ≥6 and <6, respectively), multivariate analysis showed that independent risk factors of insufficient efficacy were age at start of treatment of 40 years or more (P = 0.021) and classification on the modified Norwood–Hamilton scale (P < 0.001), whereas presence of stress at start of treatment was a negative predictor (P = 0.025). In conclusion, continuous finasteride treatment for 5 years improved androgenetic alopecia with sustained effect among Japanese. Younger age and less advanced disease at start of treatment were the key predictors of higher finasteride efficacy. 相似文献
985.
The wound/burn guidelines – 2: Guidelines for the diagnosis and treatment for pressure ulcers 下载免费PDF全文
Takao Tachibana Shinichi Imafuku Ryokichi Irisawa Masaki Ohtsuka Takafumi Kadono Hiroshi Fujiwara Yoshihide Asano Masatoshi Abe Takayuki Ishii Taiki Isei Takaaki Ito Yuji Inoue Mikio Ohtsuka Fumihide Ogawa Masanari Kodera Tamihiro Kawakami Masakazu Kawaguchi Ryuichi Kukino Takeshi Kono Keisuke Sakai Masakazu Takahara Miki Tanioka Takeshi Nakanishi Yasuhiro Nakamura Akira Hashimoto Minoru Hasegawa Masahiro Hayashi Manabu Fujimoto Takeo Maekawa Koma Matsuo Naoki Madokoro Osamu Yamasaki Yuichiro Yoshino Andres Le Pavoux Hironobu Ihn The Wound/Burn Guidelines Committee 《The Journal of dermatology》2016,43(5):469-506
The Wound/Burn Guidelines Committee consists of members commissioned by the Board of Directors of the Japanese Dermatological Association (JDA). It held several meetings and evaluations in writing since October 2008, and drafted five guidelines for the diagnosis and treatment including commentaries on wounds in general and the Guidelines for the Diagnosis and Treatment for Pressure Ulcers by taking opinions of the Scientific Committee and Board of Directors of JDA into consideration. 相似文献
986.
Before now, there has been no study of finasteride use exceeding 1 year in Japanese men with androgenetic alopecia (AGA) except the study subsequently conducted from the development phase. Since the launch of finasteride, no study in a larger population had been reported. Ethnic variation of the onset age, progressive nature and degree of hair loss of androgenetic alopecia are known. The therapeutic effect of oral finasteride (Propecia) was examined on androgenetic alopecia of Japanese men. The efficacy and safety of finasteride (1 mg tablet) was evaluated in Japanese men with AGA in the long term. The study enrolled 3177 men given finasteride 1 mg/day from January 2006 to June 2009 at our clinic. Efficacy was evaluated in 2561 men by the modified global photographic assessment; the photographs were assessed using the standardized 7-point rating scale. Safety data were assessed by interviews and laboratory tests in all men enrolled in the study. The overall effect of hair growth was seen in 2230 of 2561 men (87.1%), in whom hair greatly (11.1%), moderately (36.5%) and slightly (39.5%) increased. The response rate improved with increasing duration of treatment. Adverse reactions occurred in 0.7% (23/3177) of men; seven men discontinued treatment based on risk-benefit considerations. No specific safety problems associated with long-term use were observed. This study represents data collected at a single institution. Many patients did not receive follow-up examination. In Japanese men with AGA, oral finasteride used in the long-term study maintained progressive hair regrowth without recognized side-effect. 相似文献
987.
988.
989.
990.
Izumi Fukuda Naomi Hizuka Yukiko Ishikawa Emina Itoh Kumiko Yasumoto Yuko Murakami Akira Sata Junko Tsukada Makiko Kurimoto Yumiko Okubo Kazue Takano 《Growth hormone & IGF research》2004,14(6):693-454
Atherosclerosis and insulin resistance are common complications of adult growth hormone deficiency (GHD) and acromegaly. Circulating adiponectin, an adipocyte-derived protein, has both anti-atherogenic and insulin-sensitising effects. In this study, we measured serum adiponectin levels in patients with either adult GHD or acromegaly to clarify the impact of GH secretory states on the regulation of serum adiponectin levels. Serum adiponectin level was measured by radioimmunoassay in 32 patients with adult GHD, 49 patients with acromegaly and 25 normal subjects. The relationships between adiponectin and insulin sensitivity index assessed as quantitative insulin sensitivity check index (QUICKI), BMI, and serum GH and IGF-I levels were then investigated. The values of QUICKI were significantly lower in patients with acromegaly or adult GHD compared to normal subjects (0.33 +/- 0.03, P < 0.01, 0.35 +/- 0.04, P < 0.05 and 0.36 +/- 0.01, respectively). While patients with adult GHD had significantly lower serum adiponectin levels than patients with acromegaly (6.5 +/- 3.9, 9.2 +/- 5.0, P < 0.01) these levels were not significantly different from those found in normal subjects (7.8 +/- 4.3 mug/ml). There was an inverse correlation between serum adiponectin levels and BMI in both patient groups (GHD r = -0.39, P < 0.05; Acromegaly r = -0.35, P < 0.05). However, serum adiponectin levels correlated positively with QUICKI (R(s) = 0.37, P < 0.05) only in patients with adult GHD. In patients with acromegaly, the levels of circulating adiponectin showed an inverse correlation with serum IGF-I levels (R(s) = -0.34, P < 0.05), but not with basal GH levels. These results demonstrate that adiponectin levels are significantly lower in patients with adult GHD than in patients with acromegaly. Adiponectin levels are similar in patients with GHD and healthy controls, whereas in patients with acromegaly, insulin resistance appears to be not closely related to adiponectin levels compared with BMI. The different relationship between adiponectin and QUICKI observed in the adult GHD and acromegaly groups presumably reflects differences in the mechanisms of insulin resistance under states of GH deficiency or excess. 相似文献